# Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes

> **NCT06570278** · NA · RECRUITING · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 1020 (estimated)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DIAGNOSTIC_TEST:** WGS coupled with MCM

## Key facts

- **NCT ID:** NCT06570278
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-30
- **Primary completion:** 2031-11
- **Final completion:** 2034-11
- **Target enrollment:** 1020 (ESTIMATED)
- **Last updated:** 2026-04-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06570278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06570278, "Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06570278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*